Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70518-4056

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text contains information about Bupropion HCI, a medication in tablet form with a strength of 150 mg. It is an extended-release (SR) formula manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY. The prescription warns against using it with ZYBAN or any other medications containing Bupropion HCI. The package includes 90 tablets and recommends storing it at 20-25°C. For detailed directions on use, refer to the package insert. Repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.